Patents Assigned to GLOBE BIOMEDICAL CO., LTD.
  • Patent number: 12091378
    Abstract: The invention provides novel compounds, pharmaceutical compositions and methods of preparation and use thereof for treating disease affecting the central nervous system such as multiple sclerosis.
    Type: Grant
    Filed: May 23, 2022
    Date of Patent: September 17, 2024
    Assignees: GLOBE BIOMEDICAL CO., LTD., GLOBE HEALTH INSTITUTE LLC
    Inventors: Chiang J. Li, Suzhen Chen, Jifeng Liu